Influencing Factors for Physical Activity in People With Head and Neck Cancer

Advanced Head and Neck Squamous Cell Carcinoma Clinical Trial

— ProAct-HNC  

Official title:

Exploring Influencing Factors for Physical Activity Participation in People With Advanced Head and Neck Cancer - a Qualitative Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06272513
• Other study ID #: ProAct-HNC-02
• Status: Not yet recruiting
• Start date: March 2024
• Est. completion date: June 30, 2025

Study information

• Verified date: February 2024
• Source: Kantonsspital Winterthur KSW
• Contact: Martina Schmocker, MSc
• Phone: +41 52 266 55 68
• Email: martina.schmocker[@]uzh.ch
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this qualitative study is to explore influencing factors for physical activity participation in people affected by an advanced head and neck cancer from the perspective of people affected and their significant others. Individual interviews will be conducted with people affected by head and neck cancer and focus group interviews will be held with significant others of people being affected to answer the following research questions: - What capabilities and opportunities for physical activity participation do people with advanced head and neck cancer experience? - What motivates people with advanced head and neck cancer to be physically active? - How do significant others view capabilities, opportunities, and motivation for physical activity participation in people with head and neck cancer? The interviews will be transcribed verbatim and analysed with a structuring content analysis approach.

Description:

see attached study protocol

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 20
• Est. completion date: June 30, 2025
• Est. primary completion date: March 31, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria for people with head and neck cancer:

• minimal age 18
• diagnosis of a primary head and neck squamous cell carcinoma within the last 24 months
• oral, pharyngeal, or laryngeal cancer stage III or IV
• completed surgery and/or radio(chemo)therapy in curative intent

Exclusion criteria for people with head and neck cancer:

• not having the physical, mental, and cognitive ability to understand, follow and hold a conversation in (Swiss-)German
• treatment in palliative intent
• recurrence of the head and neck tumour (local or distant)

Inclusion criteria for significant others of people with head and neck cancer:

• minimal age 18
• being a significant other (partner, spouse, close family member or friend) of an individual with a head and neck cancer with the above-mentioned criteria
• having the permission of the individual affected by head and neck cancer to talk about their experiences

Exclusion criteria for significant others of people with head and neck cancer:

• not having the physical, mental, and cognitive ability to understand, follow and take part in a group discussion in (Swiss-)German

Related Conditions & MeSH terms

• Advanced Head and Neck Squamous Cell Carcinoma
• Head and Neck Neoplasms
• Squamous Cell Carcinoma of Head and Neck

Locations

Country	Name	City	State
n/a

Sponsors (6)

Lead Sponsor	Collaborator
Kantonsspital Winterthur KSW	Eastern Switzerland University of Applied Sciences, UMC Utrecht, University of Applied Sciences of Western Switzerland, University of Lausanne, Zurich University of Applied Sciences

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	interview transcripts	individual interviews and focus group interviews will be transcribed verbatim to be analyzed	March 2024- March 2025
Secondary	personal information of participants	characteristics of interview and focus group participants will be collected to be able to describe the study participants, including age, education level, cancer stage, treatment received, activity levels	March 2024- March 2025